Access
To read this story in full you will need to login or make a payment (see right).
News
Nature 434, 127 (10 March 2005) | doi:10.1038/434127b; Published online 9 March 2005
Gene-therapy trials to restart following cancer risk review
Erika Check
Gene-therapy trials for children suffering from severe combined immunodeficiency disease (SCID) are set to resume in the United States, despite another cancer case in a French trial of the technique.On 4 March, an advisory meeting in Rockville, Maryland, heard evidence that the cancer risk exposed by the French trial may be specific to one form of the disease, known as X-linked SCID.
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.